Insider · CIK 0001020514

LASEZKAY GEORGE M

Reports to the SEC for 5 companies · ALPHARETTA, GA

sec.gov

Transactions

Companies

Filings

CIK

0001020514

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-08	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO	AAward	+500K sh	—	—	500,000
2024-01-19	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−18K sh	$1.27	−$22.9K	466,577
2024-01-18	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO	AAward	+440K sh	—	—	439,500
2023-09-18	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO	AAward	+200K sh	—	—	200,000
2023-01-19	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−20K sh	$1.46	−$29.2K	484,577
2023-01-04	CLSDQClearside Biomedical, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO	AAward	+488K sh	—	—	487,500
2022-01-19	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−10.8K sh	$2.12	−$22.9K	504,607
2022-01-18	CLSDQClearside Biomedical, Inc.A Award	Director, CEO	AAward	+97.5K sh	—	—	515,407
2022-01-18	CLSDQClearside Biomedical, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+293K sh	—	—	292,500
2022-01-11	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−5,100 sh	$2.46	−$12.5K	417,907
2021-09-21	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−3,525 sh	$6.46	−$22.8K	423,007
2021-06-21	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−3,707 sh	$4.38	−$16.2K	426,532
2021-03-19	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−3,370 sh	$2.82	−$9,503.4	430,239
2021-03-02	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−6,000 sh	$3.37	−$20.2K	433,609
2021-01-18	CLSDQClearside Biomedical, Inc.A Award	Director, CEO	AAward	+140K sh	—	—	439,609
2021-01-18	CLSDQClearside Biomedical, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+285K sh	—	—	284,750
2020-12-21	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−3,330 sh	$2.07	−$6,893.1	299,359
2020-09-22	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−13.4K sh	$1.59	−$21.3K	302,689
2020-05-12	CLSDQClearside Biomedical, Inc.S Sale	Director, CEO	SSale	−32.2K sh	$1.99	−$64K	311,100
2020-03-11	CLSDQClearside Biomedical, Inc.A Award	Director, CEO	AAward	+50K sh	—	—	343,250
2020-01-08	CLSDQClearside Biomedical, Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+199K sh	—	—	198,750
2020-01-08	CLSDQClearside Biomedical, Inc.A Award	Director, CEO	AAward	+66.3K sh	—	—	288,250
2019-11-11	CLSDQClearside Biomedical, Inc.P Purchase	Director, CEO	PPurchase	+12K sh	$1.16	+$13.9K	222,000
2019-09-18	CLSDQClearside Biomedical, Inc.A Award	Director, CEO	AAward	+110K sh	—	—	210,000
2019-08-07	CLSDQClearside Biomedical, Inc.A Award	Director, CEO	AAward	+100K sh	—	—	100,000
2019-04-07	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director, CEO	AAward	+250K sh	—	—	250,000
2018-06-20	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director, CEO	AAward	+11.3K sh	—	—	11,250
2017-08-08	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director, CEO	AAward	+22.5K sh	—	—	22,500
2015-08-24	KUBOTA PHARMACEUTICAL HOLDINGS CO LTDRestricted Stock UnitA Award	EVP of Legal Affairs	AAward	+128K sh	—	—	127,847
2007-05-23	COLLAGENEX PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	49,000
2005-12-02	Vaneltix Pharma, Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2004-12-03	Vaneltix Pharma, Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2004-05-24	Vaneltix Pharma, Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+26K sh	—	—	26,000
1997-12-02	ALLERGAN INCM Exercise/Conversion	Vice President, Corporate Development	MExercise/Conversion	+1,250 sh	$21.06	+$26.3K	—
1997-12-02	ALLERGAN INCEmployee Stock Option (right to buy)M Exercise/Conversion	Vice President, Corporate Development	MExercise/Conversion	−1,250 sh	—	—	32,625
1997-12-02	ALLERGAN INCS Sale	Vice President, Corporate Development	SSale	−1,250 sh	$34.63	−$43.3K	1,048
1997-04-27	ALLERGAN INCF Tax Payment	Vice President, Corporate Development	FTax Payment	−57 sh	$26.50	−$1,510.5	1,048
1997-04-22	ALLERGAN INCA Award	Vice President, Corporate Development	AAward	+350 sh	—	—	—
1997-04-22	ALLERGAN INCEmployee Stock Option (right to buy)A Award	Vice President, Corporate Development	AAward	+22.4K sh	—	—	33,875

Recent filings

Accepted (ET)
Jan 104
LASEZKAY GEORGE M0001415889-25-001280
SEC(opens sec.gov)
Jan 194
LASEZKAY GEORGE M0001209191-24-001960
SEC(opens sec.gov)
Sep 204
LASEZKAY GEORGE M0001209191-23-050161
SEC(opens sec.gov)
Jan 204
LASEZKAY GEORGE M0001209191-23-004274
SEC(opens sec.gov)
Jan 64
LASEZKAY GEORGE M0001209191-23-002345
SEC(opens sec.gov)
Jan 204
LASEZKAY GEORGE M0001209191-22-004191
SEC(opens sec.gov)
Jan 134
LASEZKAY GEORGE M0001209191-22-003201
SEC(opens sec.gov)
Sep 234
LASEZKAY GEORGE M0001209191-21-057459
SEC(opens sec.gov)
Jun 234
LASEZKAY GEORGE M0001209191-21-042805
SEC(opens sec.gov)
Mar 234
LASEZKAY GEORGE M0001209191-21-022603
SEC(opens sec.gov)
Mar 34
LASEZKAY GEORGE M0001209191-21-017364
SEC(opens sec.gov)
Jan 204
LASEZKAY GEORGE M0001209191-21-004478
SEC(opens sec.gov)
Dec 234
LASEZKAY GEORGE M0001209191-20-065019
SEC(opens sec.gov)
Sep 244
LASEZKAY GEORGE M0001209191-20-051898
SEC(opens sec.gov)
May 134
LASEZKAY GEORGE M0001209191-20-028794
SEC(opens sec.gov)
Mar 134
LASEZKAY GEORGE M0001209191-20-018886
SEC(opens sec.gov)

Companies

Address

C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200

ALPHARETTA, GA, 30005